312 related articles for article (PubMed ID: 26281849)
21. Intensity normalization methods in brain FDG-PET quantification.
López-González FJ; Silva-Rodríguez J; Paredes-Pacheco J; Niñerola-Baizán A; Efthimiou N; Martín-Martín C; Moscoso A; Ruibal Á; Roé-Vellvé N; Aguiar P
Neuroimage; 2020 Nov; 222():117229. PubMed ID: 32771619
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer's disease.
Kawachi T; Ishii K; Sakamoto S; Sasaki M; Mori T; Yamashita F; Matsuda H; Mori E
Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):801-9. PubMed ID: 16550383
[TBL] [Abstract][Full Text] [Related]
23. Comparison of different methods of spatial normalization of FDG-PET brain images in the voxel-wise analysis of MCI patients and controls.
Martino ME; de Villoria JG; Lacalle-Aurioles M; Olazarán J; Cruz I; Navarro E; García-Vázquez V; Carreras JL; Desco M
Ann Nucl Med; 2013 Aug; 27(7):600-9. PubMed ID: 23585159
[TBL] [Abstract][Full Text] [Related]
24. Glucose metabolism in nine patients with probable sporadic Creutzfeldt-Jakob disease: FDG-PET study using SPM and individual patient analysis.
Renard D; Vandenberghe R; Collombier L; Kotzki PO; Pouget JP; Boudousq V
J Neurol; 2013 Dec; 260(12):3055-64. PubMed ID: 24068371
[TBL] [Abstract][Full Text] [Related]
25. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease.
Chételat G; Desgranges B; Landeau B; Mézenge F; Poline JB; de la Sayette V; Viader F; Eustache F; Baron JC
Brain; 2008 Jan; 131(Pt 1):60-71. PubMed ID: 18063588
[TBL] [Abstract][Full Text] [Related]
26. Comparison of SPM and NEUROSTAT in voxelwise statistical analysis of brain SPECT and MRI at the early stage of Alzheimer's disease.
Nishimiya M; Matsuda H; Imabayashi E; Kuji I; Sato N
Ann Nucl Med; 2008 Dec; 22(10):921-7. PubMed ID: 19142712
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of extent analysis for statistical parametric mapping with asymmetry index using inter-ictal FGD-PET in mesial temporal lobe epilepsy.
Soma T; Momose T; Takahashi M; Koyama K; Kawai K; Murase K; Ohtomo K
Ann Nucl Med; 2012 May; 26(4):319-26. PubMed ID: 22311414
[TBL] [Abstract][Full Text] [Related]
28. Cerebral Hypoperfusion and Hypometabolism Detected by Arterial Spin Labeling MRI and FDG-PET in Early-Onset Alzheimer's Disease.
Verclytte S; Lopes R; Lenfant P; Rollin A; Semah F; Leclerc X; Pasquier F; Delmaire C
J Neuroimaging; 2016; 26(2):207-12. PubMed ID: 26031943
[TBL] [Abstract][Full Text] [Related]
29. What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?
Andriuta D; Moullart V; Schraen S; Devendeville A; Meyer ME; Godefroy O;
J Alzheimers Dis; 2016; 51(3):793-800. PubMed ID: 26923012
[TBL] [Abstract][Full Text] [Related]
30. In Alzheimer's disease, hypometabolism in low-amyloid brain regions may be a functional consequence of pathologies in connected brain regions.
Klupp E; Förster S; Grimmer T; Tahmasian M; Yakushev I; Sorg C; Yousefi BH; Drzezga A
Brain Connect; 2014 Jun; 4(5):371-83. PubMed ID: 24870443
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of a new expert system for fully automated detection of the Alzheimer's dementia pattern in FDG PET.
von Borczyskowski D; Wilke F; Martin B; Brenner W; Clausen M; Mester J; Buchert R
Nucl Med Commun; 2006 Sep; 27(9):739-43. PubMed ID: 16894329
[TBL] [Abstract][Full Text] [Related]
32. Feasibility of estimation of brain volume and 2-deoxy-2-(18)F-fluoro-D-glucose metabolism using a novel automated image analysis method: application in Alzheimer's disease.
Musiek ES; Saboury B; Mishra S; Chen Y; Reddin JS; Newberg AB; Udupa JK; Detre JA; Hofheinz F; Torigian D; Alavi A
Hell J Nucl Med; 2012; 15(3):190-6. PubMed ID: 23106049
[TBL] [Abstract][Full Text] [Related]
33. A Comparison of Two Statistical Mapping Tools for Automated Brain FDG-PET Analysis in Predicting Conversion to Alzheimer's Disease in Subjects with Mild Cognitive Impairment.
Garibotto V; Trombella S; Antelmi L; Bosco P; Redolfi A; Tabouret-Viaud C; Rager O; Gold G; Giannakopoulos P; Morbelli S; Nobili F; Perneczky R; Didic M; Guedj E; Drzezga A; Ossenkoppele R; Berckel BV; Ratib O; Frisoni GB
Curr Alzheimer Res; 2020; 17(13):1186-1194. PubMed ID: 33583380
[TBL] [Abstract][Full Text] [Related]
34. A modified method of 3D-SSP analysis for amyloid PET imaging using [¹¹C]BF-227.
Kaneta T; Okamura N; Minoshima S; Furukawa K; Tashiro M; Furumoto S; Iwata R; Fukuda H; Takahashi S; Yanai K; Kudo Y; Arai H
Ann Nucl Med; 2011 Dec; 25(10):732-9. PubMed ID: 21792587
[TBL] [Abstract][Full Text] [Related]
35. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635
[TBL] [Abstract][Full Text] [Related]
36. Regional expansion of hypometabolism in Alzheimer's disease follows amyloid deposition with temporal delay.
Förster S; Grimmer T; Miederer I; Henriksen G; Yousefi BH; Graner P; Wester HJ; Förstl H; Kurz A; Dickerson BC; Bartenstein P; Drzezga A
Biol Psychiatry; 2012 May; 71(9):792-7. PubMed ID: 21679929
[TBL] [Abstract][Full Text] [Related]
37. Brain fluorodeoxyglucose (FDG) PET in dementia.
Kato T; Inui Y; Nakamura A; Ito K
Ageing Res Rev; 2016 Sep; 30():73-84. PubMed ID: 26876244
[TBL] [Abstract][Full Text] [Related]
38. Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism.
Chiba Y; Fujishiro H; Ota K; Kasanuki K; Arai H; Hirayasu Y; Sato K; Iseki E
Int J Geriatr Psychiatry; 2015 Mar; 30(3):316-23. PubMed ID: 24839913
[TBL] [Abstract][Full Text] [Related]
39. Whither the hippocampus? FDG-PET hippocampal hypometabolism in Alzheimer disease revisited.
Maldjian JA; Whitlow CT;
AJNR Am J Neuroradiol; 2012 Nov; 33(10):1975-82. PubMed ID: 22700745
[TBL] [Abstract][Full Text] [Related]
40. Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease.
Brugnolo A; De Carli F; Pagani M; Morbelli S; Jonsson C; Chincarini A; Frisoni GB; Galluzzi S; Perneczky R; Drzezga A; van Berckel BNM; Ossenkoppele R; Didic M; Guedj E; Arnaldi D; Massa F; Grazzini M; Pardini M; Mecocci P; Dottorini ME; Bauckneht M; Sambuceti G; Nobili F
J Alzheimers Dis; 2019; 68(1):383-394. PubMed ID: 30776000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
